Naked-Eye LAMP Assay of M. tuberculosis in Sputum by In Situ Au Nanoprobe Identification: For the In Vitro Diagnostics of Tuberculosis.
Xiaochang ZhangYongshuai TianYali ShiJianan LiuChenlin ZhaoChia-Chen ChangTohru TakaradaMizuo MaedaGuoqing WangPublished in: ACS infectious diseases (2024)
In spite of the development of diagnostic tests for Mycobacterium tuberculosis ( M. tuberculosis ), the etiological agent of tuberculosis, there has remained a gap between the established methods and an easily accessible diagnostic test, particularly in developing and resource-poor areas. By combining isothermal amplification of IS6110 as the target gene and recognition by DNA-functionalized Au nanoparticles (DNA-AuNPs), we develop a colorimetric LAMP assay for convenient in vitro diagnostics of tuberculosis with a quick (≤50 min) "yes" or "no" readout. The DNA-AuNPs not only tolerate the interference in the complex LAMP system but also afford in situ identification of the amplicon, allowing for colloidal dispersion via steric effect depending on DNA grafting density. The target-induced stabilization and red appearance of the DNA-AuNPs contrast with the occurrence of gray aggregates in a negative sample. Furthermore, the DNA-AuNPs demonstrate excellent performance after long-term (≥7 months) storage while preserving the unsacrificed sensitivity. The high specificity of the DNA-AuNPs is further demonstrated in the naked-eye LAMP assay of M. tuberculosis in patients' sputum samples. Given the rapidity, cost-effectiveness, and instrument-free characteristics, the naked-eye LAMP assay is particularly beneficial for tuberculosis diagnosis in urgent situations and resource-limited settings and can potentially expedite patient care and treatment initiation.
Keyphrases
- mycobacterium tuberculosis
- circulating tumor
- pulmonary tuberculosis
- cell free
- nucleic acid
- single molecule
- high throughput
- hiv aids
- loop mediated isothermal amplification
- end stage renal disease
- gold nanoparticles
- circulating tumor cells
- emergency department
- risk assessment
- chronic kidney disease
- reduced graphene oxide
- sensitive detection
- high resolution
- endothelial cells
- computed tomography
- hiv infected
- oxidative stress
- copy number
- living cells
- patient reported outcomes
- dna methylation
- fluorescent probe
- contrast enhanced